AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Newsulin 30/70 Injection

Prescription Icon
Prescription Required

Marketer

Wockhardt Ltd

Salt Composition

Human insulin (40IU)

Overview Newsulin 30/70 Injection

Diabetics using InsuLinR 30/70, a rapid-acting insulin, manage their type 1 or 2 diabetes mellitus. This injection, combined with a balanced diet and exercise, regulates post-meal glucose. This integrated approach mitigates severe diabetic complications such as renal failure and vision loss. InsuLinR 30/70 is typically administered alongside a long-acting insulin or alternative diabetes medications, with injection technique demonstrated by healthcare professionals. Administer it subcutaneously 20-30 minutes pre-meal. Discontinue only under physician guidance; it's a component of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed. Consistent blood glucose monitoring, record-keeping, and doctor consultations are crucial for dose optimization. Common side effects include hypoglycemia (low blood sugar), injection site reactions, diaphoresis, apprehension, tremor, hunger, tachycardia, cephalalgia, and irritability, often resulting from insufficient post-injection food intake. Accurate dosing, regular meals, and diligent glucose monitoring are preventative measures. Excessive alcohol consumption can also trigger hypoglycemia. Additional side effects involve injection site inflammation or erythema. Weight gain is also possible. Avoid use with pre-existing hypoglycemia. Consult your physician regarding pre-existing kidney, liver, or cardiac issues before commencing treatment. Pregnant or lactating individuals require physician consultation for potential dosage adjustments.

Uses of Newsulin 30/70 Injection

High blood sugar

Major Benefits of Newsulin 30/70 Injection:

Administering this medication will be handled by your physician or their qualified associate; self-medication is strictly prohibited.

Common Side effects of Newsulin 30/70 Injection:

  • Hypoglycemia (low blood glucose level)
  • Weight gain
  • Injection site reactions (pain, swelling, redness)
  • Cold sweat
  • Anxiety
  • Shakiness
  • Hunger pangs
  • Fast heart rate
  • Headache
  • Nervousness

How to use Newsulin 30/70 Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Newsulin 30/70 Injection works:

NovoRapid 30/70 is a rapid-acting insulin formulation initiating its effect within half an hour of administration. Its action mimics the body's natural insulin, promoting glucose uptake into muscle and adipose tissue while concurrently inhibiting hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Newsulin 30/70 Injection is dangerous.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Newsulin 30/70 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, clinical data from human subjects are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can safely use Newsulin 30/70 Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Newsulin 30/70 Injection cautiously. Dosage modification of Newsulin 30/70 Injection might be necessary. Physician consultation is advised. Routine blood glucose level checks are recommended to guide dosage changes.

LiverLiverCAUTION

Patients with hepatic impairment should use Newsulin 30/70 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Consistent blood glucose monitoring is recommended to guide appropriate dosage changes.

What if you forget to take Newsulin 30/70 Injection :

Should you miss a dose of Newsulin 30/70 Injection, elevated blood glucose (hyperglycemia) may occur. Administer the injection as soon as recalled. However, if the next scheduled dose is imminent, omit the forgotten dose and resume your usual regimen. Avoid doubling the subsequent dose to make up for the missed one.

Facts to Know About Newsulin 30/70 Injection

LabelValue
Chemical Category Analog insulin
Developing Habits No.
Treatment Category Diabetes Management
Behavioral Class Rapid-acting human insulin

FAQs on Newsulin 30/70 Injection

Type 1 diabetes requires lifelong Newsulin 30/70 injections because the body doesn't produce enough insulin. Type 2 diabetes patients, however, may discontinue Newsulin 30/70 injections if their condition is controlled through diet, exercise, and oral medication.
Newsulin 30/70 Injection can be used independently or alongside other diabetes medications, including long-acting insulin or oral medications. Optimal results require adherence to your doctor's prescribed treatment plan, which should incorporate diet and exercise.
Newsulin 30/70 is injected under the skin. Your doctor will instruct you on proper injection sites. Rotate injection sites regularly among your abdomen, buttocks, thighs, and upper arms, avoiding muscle or vein injection. Use each injection site for one to two weeks before moving to a different area, but remain within the same body area for that duration to minimize blood sugar fluctuations.
Yes, Newsulin 30/70 Injection is safe during pregnancy with a doctor's prescription. However, always inform your doctor about your pregnancy, pregnancy plans, or breastfeeding before use. Dose adjustments may be necessary, and regular blood sugar monitoring will likely be recommended. Closely follow your doctor's instructions for optimal results.
Using insulin for type 2 diabetes is safe when administered as prescribed. Regular blood sugar monitoring is crucial, and your dosage may require adjustment. Adhere to recommended lifestyle changes and discuss any side effects and their management with your doctor.
Newsulin 30/70 Injection may cause temporary injection site reactions like redness, itching, pain, or swelling. Less common is lipodystrophy, a change in fat tissue at the injection site from repeated use in the same area. This can involve fat thickening (lipohypertrophy) or thinning (lipoatrophy), potentially affecting insulin absorption. To minimize lipodystrophy risk, rotate injection sites within a given region.
Hypoglycemia is the most frequent side effect of Newsulin 30/70 Injection. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Maintain consistent meal timing and portions; eat snacks as needed after strenuous activity. Regular blood sugar monitoring is crucial. Always keep readily available sugar sources, such as candy, glucose tablets, or fruit juice, on hand. Take all prescribed medications as directed and consult your doctor regarding any blood sugar fluctuations.
Newsulin 30/70 Injection can be administered intravenously by a doctor in a hospital setting for conditions like diabetic ketoacidosis or severe hyperglycemia, but only under strict blood sugar monitoring.
Adjust your Newsulin 30/70 Injection dose after consulting your doctor if you experience weight changes, increased stress, illness, dietary changes (including missed meals), alcohol consumption, a new exercise routine, or are taking other medications. Be aware of potential side effects; your doctor can advise on prevention. While usually temporary, severe side effects may require dose adjustment.
Before first use, refrigerate Newsulin 30/70 Injection. Unopened Humalog cartridges and pens also require refrigeration (2°C to 8°C). Avoid freezing. Discard Newsulin 30/70 Injection if frozen. Once a cartridge is in the pen, store it at room temperature (below 30°C/86°F) and use within 28 days; discard afterwards, regardless of remaining contents.
Newsulin 30/70 Injection is a bioengineered insulin analog, a sterile, clear, colorless solution. This formulation combines insulin aspart with glycerin, phenol, metacresol, zinc, sodium chloride, and other components.
Newsulin 30/70 Injection
144
MRP 158
9% off